An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.

Kostova, Y; Mantwill, K; Holm, P S; Anton, M

doi:10.1038/cgt.2014.67

User: Guest

Institut für Experimentelle Onkologie und Therapieforschung

Back
Back to start of result list
Permanent link for displayed object

Title:: An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Document type:: Journal Article; Research Support, Non-U.S. Gov't
Author(s):: Kostova, Y; Mantwill, K; Holm, P S; Anton, M
Abstract:: We investigated the novel recombinant oncolytic adenovirus Ad-delo-sr39TK-RGD, armed with a mutant herpes simplex virus type 1 thymidine kinase (HSV1-sr39TK) as a suicide gene, and explored its antitumor efficacy in combination with HSV1-sr39TK/ganciclovir (GCV) gene therapy and temozolomide (TMZ). Ad-delo-sr39TK-RGD is an E1-mutated conditionally replicating adenovirus dependent on the human Y-box binding protein 1 (YB-1). Thus, we utilized the YB-1 dependency of the vector to target human glioma cells in vitro, using two-dimensional cell culture and three-dimensional multicellular spheroids, and demonstrated the strong replication competence and oncolytic potential of the virus. The cytotoxicity mediated by HSV1-sr39TK and its prodrug GCV enhanced the oncolytic effect even at <0.1 ?g ml(-1) GCV and induced cell killing of > 95% after adding GCV 0-1 days following infection. An increased bystander effect of viral replication and GCV in co-cultured infected and uninfected cells was observed. Co-administrating Ad-delo-sr39TK-RGD with TMZ and GCV, spheroid growth was reduced drastically. Gamma counting of infected spheroids demonstrated successful accumulation of the radiotracer (18)F-labeled 9-[4-fluoro-3-(hydroxymethyl)butyl]guanine mediated by HSV1-sr39TK. Hence, our results show that the combination of YB-1-dependent virotherapy with suicide genes and TMZ effectively induces glioma cell killing and may allow for in vivo non-invasive imaging within a limited time frame.
Journal title abbreviation:: Cancer Gene Ther
Year:: 2015
Journal volume:: 22
Journal issue:: 1
Pages contribution:: 30-43
Language:: eng
Fulltext / DOI:: doi:10.1038/cgt.2014.67
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/25501992
Print-ISSN:: 0929-1903
TUM Institution:: Institut für Experimentelle Onkologie und Therapieforschung
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Ehemalige Einrichtungen Institut für Experimentelle Onkologie und Therapieforschung 2015

mediaTUM Gesamtbestand Hochschulbibliographie 2015 Fakultäten Medizin Institut für Experimentelle Onkologie und Therapieforschung